DUBLIN--(BUSINESS WIRE)--

Research and Markets has announced the addition of the "MediPoint: Predictive Breast Cancer Gene Testing - Current and Future Players" report to their offering.

This report focuses on the predictive breast cancer gene testing markets in the US and Europe, and future markets in China, India and Brazil, identifying and competitively assessing current marketed and pipeline products and emerging technologies.

This report identifies the unmet needs in the market, provides an understanding of physician perception of predictive breast cancer gene testing, and future trends. To successfully market new gene tests, companies need to offer gene tests that address the current unmet needs of current predictive breast cancer gene tests and show better efficacy and cost effectiveness to the gene tests currently in the market. This report will identify the opportunities for this technology.

Scope

- Investigation of current and future market competition for predictive breast cancer gene testing.

- Competitor assessment.

- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.

- Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.

- Direct quotes from Key Opinion Leaders (KOL) as well as oncologists, geneticists and genetic counselors already using these gene tests.

Go here to see the original:
Research and Markets: MediPoint: Predictive Breast Cancer Gene Testing - Current and Future Players

Comments are closed.